Jefferies Financial Group Portfolio holdings
Jefferies Financial Group is the investment banking and capital markets company that was known as Leucadia National until 2018, when it took the name of the bank it merged with in 2013. Leucadia traces back to Ian Cumming and Joseph Steinberg, Harvard Business School graduates who started out at the investment bank Carl Marks & Company and in 1979 took control of Talcott National, renaming it Leucadia the next year. As a holding company it bought and resold businesses, such as the insurer Colonial Penn, acquired in 1991 and sold in two pieces in 1997, and the telecoms company WilTel, acquired in 2003 and sold in 2005. Jefferies itself grew from a small equities trading shop into a full-service investment bank, and Richard Handler became chief executive of the combined company in 2013.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$204M |
| 2 |
SPDR Gold Trust
GLD
|
+$94.6M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$88.3M |
| 4 |
Intel
INTC
|
+$58.2M |
| 5 |
Boeing
BA
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$640M |
| 2 |
Apple
AAPL
|
+$234M |
| 3 |
Meta Platforms (Facebook)
META
|
+$128M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$114M |
| 5 |
PTC Therapeutics
PTCT
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 59.53% |
| 2 | Healthcare | 11.13% |
| 3 | Technology | 8.29% |
| 4 | Industrials | 4.73% |
| 5 | Financials | 4.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
PUT
Insmed
INSM
$25.1B
| $12M | 0.09% |
105,400
| – | – |
2023 Q3
12 quarters
|
|
177
The RealReal
REAL
$1.77B
| $11.9M | 0.09% |
+1,349,532
| New | +$14.6M |
2026 Q3
0 quarters
|
|
178
PUT
State Street Utilities Select Sector SPDR ETF
XLU
$24.2B
| $11.9M | 0.09% |
301,300
+222,100
| +280% | +$9.7M |
2025 Q4
3 quarters
|
|
179
State Street Health Care Select Sector SPDR ETF
XLV
$50.5B
| $11.8M | 0.09% |
70,000
-80,963
| -54% | -$13.5M |
2022 Q4
15 quarters
|
|
180
PUT
AstraZeneca
AZN
$292B
| $11.7M | 0.09% |
+72,600
| New | +$12.1M |
2026 Q3
0 quarters
|
|
181
KB Home
KBH
$3.13B
| $11.7M | 0.09% |
+251,848
| New | +$13.6M |
2026 Q3
0 quarters
|
|
182
Citi Trends
CTRN
$388M
| $11.4M | 0.08% |
+221,424
| New | +$14.2M |
2026 Q3
0 quarters
|
|
183
Procore
PCOR
$11.6B
| $11.3M | 0.08% |
218,440
+164,477
| +305% | +$8.68M |
2026 Q2
1 quarter
|
|
184
Rayonier Advanced Materials
RYAM
$397M
| $11.3M | 0.08% |
1,416,981
+1,040,912
| +277% | +$8.7M |
2026 Q2
1 quarter
|
|
185
Compass Pathways
CMPS
$1.29B
| $11M | 0.08% |
884,903
-109,490
| -11% | -$1.45M |
2025 Q3
4 quarters
|
|
186
ConocoPhillips
COP
$160B
| $10.8M | 0.08% |
85,967
-12,972
| -13% | -$1.61M |
2024 Q3
8 quarters
|
|
187
Pacira BioSciences
PCRX
$1.46B
| $10.7M | 0.08% |
427,660
+57,568
| +16% | +$1.46M |
2022 Q4
15 quarters
|
|
188
DELISTED
Qorvo
QRVO
| $10.7M | 0.08% |
+93,211
| New | +$9.15M |
2026 Q3
0 quarters
|
|
189
Tractor Supply
TSCO
$19.4B
| $10.6M | 0.08% |
338,122
+272,513
| +415% | +$8.94M |
2026 Q2
1 quarter
|
|
190
PUT
VanEck Semiconductor ETF
SMH
$62.7B
| $10.5M | 0.08% |
17,200
-65,000
| -79% | -$37.2M |
2026 Q1
2 quarters
|
|
191
CALL
Coherent
COHR
$44.7B
| $10.4M | 0.08% |
36,000
+24,900
| +224% | +$7.48M |
2026 Q1
2 quarters
|
|
192
Otis Worldwide
OTIS
$30B
| $10.3M | 0.08% |
160,886
-32,350
| -17% | -$2.3M |
2025 Q4
3 quarters
|
|
193
Cintas
CTAS
$88.2B
| $10.3M | 0.08% |
53,050
+22,553
| +74% | +$4.48M |
2023 Q1
14 quarters
|
|
194
PUT
Bank of America
BAC
$349B
| $10.2M | 0.08% |
188,300
+97,000
| +106% | +$5.91M |
2024 Q4
7 quarters
|
|
195
IDEX
IEX
$17.2B
| $10.2M | 0.08% |
44,833
+1,217
| +3% | +$277K |
2025 Q1
6 quarters
|
|
196
CALL
JPMorgan Chase
JPM
$907B
| $10.2M | 0.08% |
+30,800
| New | +$10.8M |
2026 Q3
0 quarters
|
|
197
PUT
Morgan Stanley
MS
$295B
| $9.8M | 0.07% |
+52,200
| New | +$11.1M |
2026 Q3
0 quarters
|
|
198
Tapestry
TPR
$26.4B
| $9.8M | 0.07% |
85,041
-614,023
| -88% | -$82.1M |
2025 Q3
4 quarters
|
|
199
Huntington Bancshares
HBAN
$32.2B
| $9.8M | 0.07% |
+639,696
| New | +$10.9M |
2026 Q3
0 quarters
|
|
200
Vanguard FTSE Emerging Markets ETF
VWO
$120B
| $9.7M | 0.07% |
163,321
+1,833
| +1% | +$109K |
2025 Q2
5 quarters
|
|
Similar funds
Jefferies Financial Group's Q3 2026 Portfolio in Review
As of Q3 2026, Jefferies Financial Group held 1,968 positions worth $13.5B, down 11% from $15.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Jefferies Financial Group withdrew a net $3.53B in Q3 2026, closing 703 positions and reducing 401 holdings. Its most notable exit was PTC Therapeutics, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 60% of assets, up from 50% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Jefferies Financial Group opened a new position in Emcor worth $40.1M.
- Jefferies Financial Group's largest Q3 2026 buy was Emcor: 53,175 shares worth $40.1M.
- Jefferies Financial Group added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2026, an estimated $204M increase.
- Jefferies Financial Group's biggest Q3 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $640M.
- Jefferies Financial Group fully exited PTC Therapeutics in Q3 2026, selling an estimated $111M.
- Jefferies Financial Group's ten largest holdings make up 34% of its $13.5B portfolio in Q3 2026.
- Jefferies Financial Group opened 337 new positions and closed 703 in Q3 2026.
- Jefferies Financial Group's portfolio value fell 11% quarter-over-quarter to $13.5B.
Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.